Skip to main content
. 2021 May 5;321(1):G1–G10. doi: 10.1152/ajpgi.00425.2020

Figure 1.

Figure 1.

Roadmap to organoid-based therapy. The roadmap identifies the four critical areas that need to be considered when developing a cellular therapy intended for evaluation in human clinical studies under an investigational new drug (IND) application: basic research, resource and preclinical development, and IND assembly and submission. POC, proof-of-concept; CGMP, current good manufacturing practice.